My desire won't be satiated until I see $1000 million in FY revenue.
The more time passes and the more that NovoSorb's remarkable features and potential uses are revealed the more I'm convinced that this is a reasonable expectation.
While I admit to being long in the tooth, I still reckon that it won't take too long for this goal to be met and I'll still have enough life in me to enjoy the benefits.
Trading update Q3 FY23, page-2
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.01 |
Change
0.000(0.00%) |
Mkt cap ! $1.387B | |||
| Open | High | Low | Value | Volume |
| $2.03 | $2.08 | $2.01 | $4.152M | 2.047M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1445 | $2.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.03 | 2769 | 1 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.03 |
Change
0.000 ( 0.64 %) |
||||
| Open | High | Low | Volume | ||
| $2.03 | $2.08 | $2.01 | 385950 | ||
| Last updated 15.59pm 02/05/2024 ? | |||||
| PNV (ASX) Chart |